Monsanto Roundup Lawsuit

Thursday, December 18, 2008

KA-CHING FOR EMORY AND NEMEROFF

More stories appearing about disgraced psychiatrist, Dr. Charles Nemeroff, in today's press and blogs.

The Wall Street Journal carries the headline: 'Grassley Blasts Emory over ‘CME-Like’ Defense of Nemeroff' and reports how Sen. Charles Grassley is accusing Emory University of making up a new term in an effort to defend its star psychiatrist from accusations he failed to properly report hundreds of thousands of dollars in payments from drug companies during this decade.

In explaining why psychiatrist Charles Nemeroff failed to report payments from GlaxoSmithKline, Emory said Nemeroff reported to them that some of the payments from Glaxo, maker of antidepressant Paxil, were for talks that weren’t promotional in nature but instead were “CME-like.” Calls to Emory and Nemeroff for comment weren’t returned immediately.

The Wall Street Journal Blog reports on how Nemeroff wrote himself a cheque for $3000 for writing an article on Effexor, an antidepressant.

Meantime, The New York Times goes with a story where psychiatrists are 'revising the book of human troubles'.

If we let these psychiatrists write what I think they are going to write then we are going to have one major problem on our hands. It seems some of the questions being thrown into the pot are, Is compulsive shopping a mental problem? Do children who continually recoil from sights and sounds suffer from sensory problems — or just need extra attention? Should a fetish be considered a mental disorder, as many now are?

The book, the Diagnostic and Statistical Manual of Mental Disorders or [DSM-V] is both a medical guidebook and a cultural institution. It helps doctors make a diagnosis. We are heading into the abyss folks and Pharma will be throwing us one by one into that abyss is this book of absurdity sees the light of day.

It's been said that scientists who accepted the invitation to work on the new manual agreed to limit their income from drug makers and other sources to $10,000 a year for the duration of the job.

Hopefully they may find a cure for Pharmaceutical greed.

Fid




Fid

Read the new book, The Evidence, However, Is Clear...The Seroxat Scandal

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

Post a Comment